ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

NZM2 Novonesis AS

57,88
-0,28 (-0,48%)
20:31:38 - Données en temps réel
Nom Action Symbole Action Marché Type
Novonesis AS NZM2 Tradegate Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,28 -0,48% 57,88 20:31:38
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
58,52 57,68 58,60 58,16
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/6/202414:08GLOBEMajor shareholder announcement
21/6/202411:54GLOBETrading by management and close relations of management
21/6/202411:53GLOBEMajor shareholder announcement
17/6/202419:09GLOBEThe era of biosolutions. Outlook upgraded for 2024
06/6/202411:28GLOBEIncentive programs for the Executive Leadership Team, the..
31/5/202411:25GLOBETrading by management and close relations of management
29/5/202416:59GLOBETrading by management and close relations of management
17/5/202412:39GLOBETrading by management and close relations of management
08/5/202415:21GLOBETrading by management and close relations of management
03/5/202407:57GLOBEQ1 update: Novonesis delivers 4% organic sales growth in..
03/5/202407:56GLOBETrading statement Q1 2024
30/4/202418:02GLOBEResolutions from the annual shareholders’ meeting 2024
08/4/202415:17GLOBEInvitation to the annual shareholders’ meeting
08/4/202411:58GLOBEShare-based legacy RSU program granted
21/3/202407:26GLOBE2024 outlook and pro forma financials
18/3/202415:26GLOBENovonesis will host a conference call regarding 2024 outlook..
04/3/202417:06GLOBEResolutions from the Extraordinary Shareholders’ Meeting..
09/2/202410:00GLOBEInvitation to an extraordinary shareholders’ meeting of..
08/2/202419:52GLOBEThe Novozymes Report 2023
02/2/202414:13GLOBETrading by management and close relations of management
02/2/202408:28GLOBESettlement of the combination of Novozymes and Chr. Hansen..
01/2/202408:00GLOBELegacy Novozymes delivers solid last full-year results
01/2/202407:59GLOBEResults update for 2023 – unaudited
31/1/202414:20GLOBETotal number of voting rights and capital on January 31,..
29/1/202415:59GLOBETrading by management and close relations of management
29/1/202413:13GLOBEMajor shareholder announcement
29/1/202411:27GLOBEThe combination of Novozymes and Chr. Hansen is now..
29/1/202411:25GLOBECompletion of the combination between Novozymes and Chr...
26/1/202412:06GLOBEAll necessary regulatory approvals have been obtained for..
20/12/202315:00GLOBESouth Korean merger approval granted
13/12/202314:46GLOBENovozymes’ updated financial calendar
12/12/202317:10GLOBEUpdate on the merger approval process for the combination of..
24/11/202310:20GLOBETrading by management and close relations of management
20/11/202308:00GLOBEUpdate on merger EC offered remedy proposal
09/11/202308:51GLOBENovozymes launches Quara® LowP for renewable diesel..
30/10/202315:11GLOBETrading by management and close relations of management
26/10/202308:01GLOBENovozymes accelerates growth in Q3 and is on track to..
26/10/202307:59GLOBEInterim report for 9M 2023
12/10/202312:02GLOBEInterim dividend payment
10/10/202307:59GLOBEExecutive Leadership Team and organizational structure..
04/9/202311:47GLOBEUpdate on the combination of Novozymes and Chr. Hansen:..